P/E ratio for Chemed (CHE)
P/E ratio as of April 2024 (TTM): 37.1
According to Chemed's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 37.081. At the end of 2022 the company had a P/E ratio of 30.5.
P/E ratio history for Chemed from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 30.5 | -0.98% |
| 2021 | 30.8 | 15.94% |
| 2020 | 26.6 | -16.7% |
| 2019 | 31.9 | 44.24% |
| 2018 | 22.1 | -44.36% |
| 2017 | 39.8 | 64.89% |
| 2016 | 24.1 | 5.31% |
| 2015 | 22.9 | 25.5% |
| 2014 | 18.3 | 1.47% |
| 2013 | 18.0 | 24.29% |
| 2012 | 14.5 | 18.4% |
| 2011 | 12.2 | -30.34% |
| 2010 | 17.5 | 20.33% |
| 2009 | 14.6 | 5.59% |
| 2008 | 13.8 | -35.5% |
| 2007 | 21.4 | 12.32% |
| 2006 | 19.1 | -46.28% |
| 2005 | 35.5 | 14.74% |
| 2004 | 30.9 | -130.86% |
| 2003 | -100 | 13.4% |
| 2002 | -88.4 | 228.47% |
| 2001 | -26.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 LHC Group LHCG | 82.4 | 122.30% | 🇺🇸 USA |
 Amedisys AMED | 912 | 2,360.56% | 🇺🇸 USA |
 Balchem BCPC | 44.6 | 20.15% | 🇺🇸 USA |
 Sensient Technologies
SXT | 22.5 | -39.22% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.